- Search for Research Summaries, Reviews, and Reports
Maintenance NoticeAn infrastructure upgrade will take place on Friday, December 19 at approximately 2PM Eastern time. Please be aware you may experience temporary issues accessing the site at that point.
- DEcIDE Project
- Outcomes of COPD Management
- Research Report Dec. 4, 2009
Related Links for this Topic
- Lee TA, Schumock GT, Bartle B, et al. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease. Pharmacotherapy 2009;29:1039-53.
- Pickard AS, Lee TA, Solem CT, et al. Prioritizing comparative-effectiveness research topics via stakeholder involvement: an application in COPD. Clin Pharmacol Ther 2011 Nov 2 [Epub ahead of print]. PMID: 22048220.
Abstract - Final
Outcomes of COPD Management
The prevalence of chronic obstructive pulmonary disease (COPD) is high in the United States and continues to increase. Medication management is an integral part of treatment for patients with COPD. However, there remains a great deal of uncertainty in the optimal medication management of patients with COPD and a need for long-term evaluations of medication treatment outcomes in patients with COPD to better inform decisions when caring for these patients. The goal of this project is to identify and prioritize key questions related to the management of patients with COPD and conduct an analysis of the key question(s). The specific objectives for this project are:
- Identify, review and assess major administrative, utilization, and/or claims databases, under the auspice of federal/state governments, third party payers, health plans/networks, or provider consortiums, that contain relevant prescription drug, surgical, outcome and utilization data for people with COPD;
- Identify a set of clinically relevant key questions relating to effectiveness of medical therapy for patients with COPD which can be adequately evaluated using the identified data sets; and
- Conduct a secondary data analysis to evaluate the key question(s), for outcomes including mortality, outpatient and inpatient hospitalization, and COPD-related hospitalizations and ED visits.
The project will be completed in three phases, with a phase dedicated to each of the specific aims. The project has the potential to provide information relevant to health care provider organizations in policy formation about pharmacotherapy for COPD.
*To receive a print copy of either of these reports, send a request to firstname.lastname@example.org. Please include the report title(s) and a complete mailing address. For electronic copies of the report(s), please visit the appropriate journal Web siteReturn to Top of Page